MLA
ABT icon

MB, Levis & Associates’s Abbott ABT Stock Holding History

MB, Levis & Associates’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Sell
15,119
-369
-2% -$33.7K 0.51% 34
2026
Q1 		$1.59M Sell
15,488
-44
-0.3% -$4.97K 0.66% 29
2025
Q4 		$1.95M Sell
15,532
-195
-1% -$24.8K 0.82% 23
2025
Q3 		$2.11M Sell
15,727
-1,543
-9% -$203K 0.91% 21
2025
Q2 		$2.35M Buy
17,270
+17
+0.1% +$2.24K 1.03% 18
2025
Q1 		$2.29M Sell
17,253
-42
-0.2% -$5.34K 1.06% 18
2024
Q4 		$1.96M Sell
17,295
-65
-0.4% -$7.51K 0.98% 17
2024
Q3 		$1.98M Buy
17,360
+6
+0% +$658 0.98% 19
2024
Q2 		$1.8M Buy
17,354
+114
+0.7% +$12.1K 0.95% 19
2024
Q1 		$1.96M Buy
17,240
+100
+0.6% +$11.5K 1.05% 18
2023
Q4 		$1.89M Buy
17,140
+38
+0.2% +$3.8K 1.08% 17
2023
Q3 		$1.66M Buy
17,102
+19
+0.1% +$2K 1.07% 19
2023
Q2 		$1.86M Buy
17,083
+25
+0.1% +$2.67K 1.19% 18
2023
Q1 		$1.73M Sell
17,058
-1
-0% -$106 1.2% 18
2022
Q4 		$1.87M Buy
+17,059
New +$1.77M 1.47% 16

Other funds holding ABT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

MB, Levis & Associates's ABT Position: Q2 2026 in Review

MB, Levis & Associates reduced its Abbott (ABT) stake by 2.4% in Q2 2026, selling an estimated $33.7K and leaving 15,119 shares worth $1.37M. The position accounts for 0.51% of the portfolio, ranked #34.

MB, Levis & Associates first reported a position in ABT in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.35M in Q2 2025. 2,956 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • MB, Levis & Associates held 15,119 shares of Abbott worth $1.37M as of Q2 2026.
  • MB, Levis & Associates sold 369 Abbott shares in Q2 2026, an estimated $33.7K.
  • Abbott made up 0.51% of MB, Levis & Associates's portfolio in Q2 2026, its #34 holding.
  • MB, Levis & Associates first reported a position in Abbott in Q4 2022 and has held it in 15 quarters since.
  • MB, Levis & Associates's Abbott position peaked at $2.35M in Q2 2025.
  • 2,956 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.